{"id":382691,"date":"2020-11-17T07:33:15","date_gmt":"2020-11-17T12:33:15","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=382691"},"modified":"2020-11-17T07:33:15","modified_gmt":"2020-11-17T12:33:15","slug":"progenity-to-present-at-2020-san-antonio-breast-cancer-virtual-symposium","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/progenity-to-present-at-2020-san-antonio-breast-cancer-virtual-symposium\/","title":{"rendered":"Progenity to Present at 2020\u00a0San Antonio Breast Cancer Virtual Symposium"},"content":{"rendered":"
\n

SAN DIEGO, Nov. 17, 2020 (GLOBE NEWSWIRE) — Progenity<\/a>, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products, will be presenting at the San Antonio Breast Cancer Virtual Symposium (SABCS) set to take place December 8-11, 2020.<\/p>\n

The data presented will be a part of the event\u2019s Spotlight Session Poster Presenters. Details of the presentation are as follows:<\/p>\n

\n Title –<\/strong>
\n Describing the cancer spectrum in families with CHEK2 pathogenic and likely pathogenic variants by mutation type<\/strong>
\n
Authors – Julia G Moroney, MS, CGC, and Michele S. Basiliere, MS, CGC
Poster number – PS8-18
Date and time – Wednesday, December 9, 2020: 8:00 AM CT<\/p>\n

SABCS anticipates publishing abstracts in late November 2020 and posters on December 9, 2020. The poster presentation will also be made available on the Progenity website<\/a> following the conference.<\/p>\n

\n About Progenity<\/strong>
\n
Progenity, Inc. is a biotechnology company with an established track record of success in developing and commercializing molecular testing products, as well as innovating in the field of precision medicine. Progenity provides in vitro molecular tests designed to improve lives by providing actionable information that helps guide patients and physicians in making medical decisions during key life stages. The company applies a multi-omics approach, combining genomics, epigenomics, proteomics, and metabolomics to its molecular testing products and to the development of a suite of investigational ingestible devices designed to provide precise diagnostic sampling and drug delivery solutions. Progenity\u2019s vision is to transform healthcare to become more precise and personal by improving diagnoses of disease and improving patient outcomes through localized treatment with targeted therapies. For additional information about Progenity, please visit the company\u2019s website at\u00a0www.progenity.com<\/a>.<\/p>\n

\n Investor Contact:<\/strong>
\n
Robert Uhl
Managing Director, Westwicke ICR
ir@progenity.com<\/a>
(619) 228-5886<\/p>\n

\n Media Contact:<\/strong>
\n
Kate Blom-Lowery
CG Life
media@progenity<\/a>.com<\/a>
(619)743-6294<\/p>\n

\n
\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

SAN DIEGO, Nov. 17, 2020 (GLOBE NEWSWIRE) — Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products, will be presenting at the San Antonio Breast Cancer Virtual Symposium (SABCS) set to take place December 8-11, 2020. The data presented will be a part of the event\u2019s Spotlight Session Poster Presenters. Details of the presentation are as follows: Title – Describing the cancer spectrum in families with CHEK2 pathogenic and likely pathogenic variants by mutation type Authors – Julia G Moroney, MS, CGC, and Michele S. Basiliere, MS, CGC Poster number – PS8-18Date and time – Wednesday, December 9, 2020: 8:00 AM CT SABCS anticipates publishing abstracts in late … <\/p>\n

Continue reading “Progenity to Present at 2020\u00a0San Antonio Breast Cancer Virtual Symposium”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-382691","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nProgenity to Present at 2020\u00a0San Antonio Breast Cancer Virtual Symposium - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/progenity-to-present-at-2020-san-antonio-breast-cancer-virtual-symposium\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Progenity to Present at 2020\u00a0San Antonio Breast Cancer Virtual Symposium - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO, Nov. 17, 2020 (GLOBE NEWSWIRE) — Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products, will be presenting at the San Antonio Breast Cancer Virtual Symposium (SABCS) set to take place December 8-11, 2020. The data presented will be a part of the event\u2019s Spotlight Session Poster Presenters. Details of the presentation are as follows: Title – Describing the cancer spectrum in families with CHEK2 pathogenic and likely pathogenic variants by mutation type Authors – Julia G Moroney, MS, CGC, and Michele S. Basiliere, MS, CGC Poster number – PS8-18Date and time – Wednesday, December 9, 2020: 8:00 AM CT SABCS anticipates publishing abstracts in late … Continue reading "Progenity to Present at 2020\u00a0San Antonio Breast Cancer Virtual Symposium"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/progenity-to-present-at-2020-san-antonio-breast-cancer-virtual-symposium\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-17T12:33:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NzMxNiMzODMwNjE5IzIxOTQ1MTc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/progenity-to-present-at-2020-san-antonio-breast-cancer-virtual-symposium\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/progenity-to-present-at-2020-san-antonio-breast-cancer-virtual-symposium\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Progenity to Present at 2020\u00a0San Antonio Breast Cancer Virtual Symposium\",\"datePublished\":\"2020-11-17T12:33:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/progenity-to-present-at-2020-san-antonio-breast-cancer-virtual-symposium\\\/\"},\"wordCount\":308,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/progenity-to-present-at-2020-san-antonio-breast-cancer-virtual-symposium\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NzMxNiMzODMwNjE5IzIxOTQ1MTc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/progenity-to-present-at-2020-san-antonio-breast-cancer-virtual-symposium\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/progenity-to-present-at-2020-san-antonio-breast-cancer-virtual-symposium\\\/\",\"name\":\"Progenity to Present at 2020\u00a0San Antonio Breast Cancer Virtual Symposium - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/progenity-to-present-at-2020-san-antonio-breast-cancer-virtual-symposium\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/progenity-to-present-at-2020-san-antonio-breast-cancer-virtual-symposium\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NzMxNiMzODMwNjE5IzIxOTQ1MTc=\",\"datePublished\":\"2020-11-17T12:33:15+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/progenity-to-present-at-2020-san-antonio-breast-cancer-virtual-symposium\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/progenity-to-present-at-2020-san-antonio-breast-cancer-virtual-symposium\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/progenity-to-present-at-2020-san-antonio-breast-cancer-virtual-symposium\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NzMxNiMzODMwNjE5IzIxOTQ1MTc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NzMxNiMzODMwNjE5IzIxOTQ1MTc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/progenity-to-present-at-2020-san-antonio-breast-cancer-virtual-symposium\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Progenity to Present at 2020\u00a0San Antonio Breast Cancer Virtual Symposium\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Progenity to Present at 2020\u00a0San Antonio Breast Cancer Virtual Symposium - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/progenity-to-present-at-2020-san-antonio-breast-cancer-virtual-symposium\/","og_locale":"en_US","og_type":"article","og_title":"Progenity to Present at 2020\u00a0San Antonio Breast Cancer Virtual Symposium - Market Newsdesk","og_description":"SAN DIEGO, Nov. 17, 2020 (GLOBE NEWSWIRE) — Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products, will be presenting at the San Antonio Breast Cancer Virtual Symposium (SABCS) set to take place December 8-11, 2020. The data presented will be a part of the event\u2019s Spotlight Session Poster Presenters. Details of the presentation are as follows: Title – Describing the cancer spectrum in families with CHEK2 pathogenic and likely pathogenic variants by mutation type Authors – Julia G Moroney, MS, CGC, and Michele S. Basiliere, MS, CGC Poster number – PS8-18Date and time – Wednesday, December 9, 2020: 8:00 AM CT SABCS anticipates publishing abstracts in late … Continue reading \"Progenity to Present at 2020\u00a0San Antonio Breast Cancer Virtual Symposium\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/progenity-to-present-at-2020-san-antonio-breast-cancer-virtual-symposium\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-17T12:33:15+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NzMxNiMzODMwNjE5IzIxOTQ1MTc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/progenity-to-present-at-2020-san-antonio-breast-cancer-virtual-symposium\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/progenity-to-present-at-2020-san-antonio-breast-cancer-virtual-symposium\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Progenity to Present at 2020\u00a0San Antonio Breast Cancer Virtual Symposium","datePublished":"2020-11-17T12:33:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/progenity-to-present-at-2020-san-antonio-breast-cancer-virtual-symposium\/"},"wordCount":308,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/progenity-to-present-at-2020-san-antonio-breast-cancer-virtual-symposium\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NzMxNiMzODMwNjE5IzIxOTQ1MTc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/progenity-to-present-at-2020-san-antonio-breast-cancer-virtual-symposium\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/progenity-to-present-at-2020-san-antonio-breast-cancer-virtual-symposium\/","name":"Progenity to Present at 2020\u00a0San Antonio Breast Cancer Virtual Symposium - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/progenity-to-present-at-2020-san-antonio-breast-cancer-virtual-symposium\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/progenity-to-present-at-2020-san-antonio-breast-cancer-virtual-symposium\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NzMxNiMzODMwNjE5IzIxOTQ1MTc=","datePublished":"2020-11-17T12:33:15+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/progenity-to-present-at-2020-san-antonio-breast-cancer-virtual-symposium\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/progenity-to-present-at-2020-san-antonio-breast-cancer-virtual-symposium\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/progenity-to-present-at-2020-san-antonio-breast-cancer-virtual-symposium\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NzMxNiMzODMwNjE5IzIxOTQ1MTc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NzMxNiMzODMwNjE5IzIxOTQ1MTc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/progenity-to-present-at-2020-san-antonio-breast-cancer-virtual-symposium\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Progenity to Present at 2020\u00a0San Antonio Breast Cancer Virtual Symposium"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/382691","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=382691"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/382691\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=382691"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=382691"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=382691"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}